These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17010149

  • 21. Hormonal intrauterine devices.
    Rybo G, Andersson K, Odlind V.
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [Abstract] [Full Text] [Related]

  • 22. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF.
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [Abstract] [Full Text] [Related]

  • 23. Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel.
    Hurskainen R, Salmi A, Paavonen J, Teperi J, Rutanen E.
    Mol Hum Reprod; 2000 Nov; 6(11):1013-8. PubMed ID: 11044464
    [Abstract] [Full Text] [Related]

  • 24. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET, Yigit R, Molenberghs G, Straetmans D, Ombelet W.
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [Abstract] [Full Text] [Related]

  • 25. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
    Bergeron C, Laberge PY, Boutin A, Thériault MA, Valcourt F, Lemyre M, Maheux-Lacroix S.
    Hum Reprod Update; 2020 Feb 28; 26(2):302-311. PubMed ID: 31990359
    [Abstract] [Full Text] [Related]

  • 26. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr 10; 102(1):74-9. PubMed ID: 12039094
    [Abstract] [Full Text] [Related]

  • 27. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
    Wiewel-Verschueren S, Knol HM, Lisman T, Bogchelman DH, Kluin-Nelemans JC, van der Zee AG, Mulder AB, Meijer K.
    J Thromb Haemost; 2014 Sep 10; 12(9):1488-93. PubMed ID: 24954113
    [Abstract] [Full Text] [Related]

  • 28. Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system.
    Wildemeersch D, Rowe PJ.
    Contraception; 2004 Aug 10; 70(2):165-8. PubMed ID: 15288223
    [Abstract] [Full Text] [Related]

  • 29. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun 10; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 30. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
    Gupta JK, Daniels JP, Middleton LJ, Pattison HM, Prileszky G, Roberts TE, Sanghera S, Barton P, Gray R, Kai J, ECLIPSE Collaborative Group.
    Health Technol Assess; 2015 Oct 10; 19(88):i-xxv, 1-118. PubMed ID: 26507206
    [Abstract] [Full Text] [Related]

  • 31. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
    Campos RR, Baêta T, Silva-Filho A, Rezende SM, Rocha ALL.
    Contraception; 2020 Oct 10; 102(4):254-258. PubMed ID: 32470465
    [Abstract] [Full Text] [Related]

  • 32. The levonorgestrel intrauterine system: therapeutic aspects.
    Luukkainen T.
    Steroids; 2000 Oct 10; 65(10-11):699-702. PubMed ID: 11108879
    [Abstract] [Full Text] [Related]

  • 33. Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases.
    Papadakis EP, El-Nashar SA, Laughlin-Tommaso SK, Shazly SA, Hopkins MR, Breitkopf DM, Famuyide AO.
    J Minim Invasive Gynecol; 2015 Oct 10; 22(7):1203-7. PubMed ID: 26122898
    [Abstract] [Full Text] [Related]

  • 34. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M.
    Fertil Steril; 1997 Sep 10; 68(3):426-9. PubMed ID: 9314908
    [Abstract] [Full Text] [Related]

  • 35. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
    Cameron IT.
    Eur J Contracept Reprod Health Care; 2001 Jan 10; 6 Suppl 1():27-32. PubMed ID: 11336431
    [Abstract] [Full Text] [Related]

  • 36. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
    Fong YF, Singh K.
    Contraception; 1999 Sep 10; 60(3):173-5. PubMed ID: 10640162
    [Abstract] [Full Text] [Related]

  • 37. Synergistic effect on the treatment of menorrhagia by endometrial biopsy followed by contemporaneous insertion of the levonorgestrel intrauterine system.
    Baron YM, Craus J, Agius RC, Brincat M.
    Gynecol Endocrinol; 2012 Sep 10; 28(9):694-8. PubMed ID: 22304721
    [Abstract] [Full Text] [Related]

  • 38. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts.
    Ueyama M, Kasatori N, Urayama T, Maemura T, Yao Y, Shiraishi T, Saito S, Kubo H.
    Thromb Res; 2002 Nov 25; 108(4):235-44. PubMed ID: 12617987
    [Abstract] [Full Text] [Related]

  • 39. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
    Tang GW, Lo SS.
    Contraception; 1995 Apr 25; 51(4):231-5. PubMed ID: 7796588
    [Abstract] [Full Text] [Related]

  • 40. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S, Kelekci KH, Yilmaz B.
    Contraception; 2012 Nov 25; 86(5):458-63. PubMed ID: 22832203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.